| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal anchor activity | 2.67e-05 | 24 | 147 | 4 | GO:0008093 | |
| GeneOntologyMolecularFunction | mechanosensitive monoatomic ion channel activity | 2.94e-04 | 18 | 147 | 3 | GO:0008381 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 3.19e-04 | 231 | 147 | 8 | GO:0005085 | |
| GeneOntologyMolecularFunction | cytoskeletal protein-membrane anchor activity | 3.20e-04 | 4 | 147 | 2 | GO:0106006 | |
| GeneOntologyMolecularFunction | phosphoprotein phosphatase activity | 5.09e-04 | 189 | 147 | 7 | GO:0004721 | |
| GeneOntologyMolecularFunction | antiporter activity | 5.56e-04 | 138 | 147 | 6 | GO:0015297 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | NPR1 GALK1 KALRN ACVR2B TXK LIMK2 MAPK14 PIK3C2B CSNK2A1 PRKD1 MAPK13 CSNK2A3 CDK2 EPHA5 | 7.64e-04 | 709 | 147 | 14 | GO:0016773 |
| GeneOntologyMolecularFunction | sodium:bicarbonate symporter activity | 7.92e-04 | 6 | 147 | 2 | GO:0008510 | |
| GeneOntologyMolecularFunction | mechanosensitive monoatomic cation channel activity | 1.10e-03 | 7 | 147 | 2 | GO:0140135 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.12e-03 | 28 | 147 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | protein serine/threonine phosphatase activity | 1.28e-03 | 109 | 147 | 5 | GO:0004722 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | DOCK1 AGAP5 ARHGAP24 KALRN TSC2 RCC2 DENND3 TIAM2 VPS9D1 ARHGEF10 DENND2C | 1.35e-03 | 507 | 147 | 11 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | DOCK1 AGAP5 ARHGAP24 KALRN TSC2 RCC2 DENND3 TIAM2 VPS9D1 ARHGEF10 DENND2C | 1.35e-03 | 507 | 147 | 11 | GO:0030695 |
| GeneOntologyMolecularFunction | alpha-actinin binding | 1.51e-03 | 31 | 147 | 3 | GO:0051393 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | PRPSAP2 NPR1 GALK1 KALRN ACVR2B TXK PARP4 LIMK2 MAPK14 PIK3C2B CSNK2A1 PRKD1 MAPK13 CSNK2A3 CDK2 EPHA5 | 1.52e-03 | 938 | 147 | 16 | GO:0016772 |
| GeneOntologyMolecularFunction | kinase activity | NPR1 GALK1 KALRN ACVR2B TXK LIMK2 MAPK14 PIK3C2B CSNK2A1 PRKD1 MAPK13 CSNK2A3 CDK2 EPHA5 | 1.55e-03 | 764 | 147 | 14 | GO:0016301 |
| GeneOntologyMolecularFunction | protein kinase activity | NPR1 KALRN ACVR2B TXK LIMK2 MAPK14 CSNK2A1 PRKD1 MAPK13 CSNK2A3 CDK2 EPHA5 | 1.64e-03 | 600 | 147 | 12 | GO:0004672 |
| GeneOntologyMolecularFunction | bicarbonate transmembrane transporter activity | 1.66e-03 | 32 | 147 | 3 | GO:0015106 | |
| GeneOntologyMolecularFunction | solute:inorganic anion antiporter activity | 1.66e-03 | 32 | 147 | 3 | GO:0005452 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | DOCK1 ARHGAP24 SYNE1 PIEZO1 SYNPO2L TFIP11 SRCIN1 USP16 RCC2 TGFB3 SPTBN4 CLIP3 LIMK2 SRPX2 CEP120 ARHGEF10 SETD5 MTM1 MTMR3 NR1H2 PRKD1 BAIAP2 CDH5 PHLDB2 CDK2 RAB11FIP3 | 3.81e-07 | 1189 | 149 | 26 | GO:0044087 |
| GeneOntologyBiologicalProcess | striated muscle cell development | 3.74e-06 | 89 | 149 | 7 | GO:0055002 | |
| GeneOntologyBiologicalProcess | striated muscle cell differentiation | DOCK1 NRAP SYNE1 PIEZO1 SYNPO2L NEO1 MAPK14 PPP3CA MYL9 MYPN PRKD1 PLEC DMD | 5.46e-06 | 391 | 149 | 13 | GO:0051146 |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | DOCK1 NPR1 ARHGAP24 NRAP ANK2 SH2B3 COL27A1 DUSP4 SYNPO2L DVL2 TSC2 ACVR2B TGFB3 JUP NEO1 SRPX2 MAPK14 MYL9 MYPN MMRN2 PRKD1 KLHL12 PLEC CDH5 NOTCH2 PHLDB2 EPHA5 | 7.26e-06 | 1483 | 149 | 27 | GO:0048646 |
| GeneOntologyBiologicalProcess | muscle cell differentiation | DOCK1 NRAP ANK2 SYNE1 PIEZO1 SYNPO2L NEO1 MAPK14 PPP3CA MYL9 MYPN PRKD1 PLEC DMD NOTCH2 | 7.31e-06 | 531 | 149 | 15 | GO:0042692 |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | ARHGAP24 KALRN SYNE1 DVL2 TSC2 SRCIN1 ADCY6 RCC2 TIAM2 TGFB3 LIMK2 NEO1 PPP2R5D PPP3CA CEP120 PRKD1 BAIAP2 DMD RAB11FIP3 | 1.52e-05 | 863 | 149 | 19 | GO:0031344 |
| GeneOntologyBiologicalProcess | cell morphogenesis | KALRN SYNE1 COL27A1 DVL2 MGLL TSC2 SRCIN1 CPNE5 TIAM2 SPTBN4 DIP2A NEO1 MAPK14 PPP3CA CELSR3 CABP4 MYPN BAIAP2 PLEC DMD CDH5 NOTCH2 EPHA5 | 1.57e-05 | 1194 | 149 | 23 | GO:0000902 |
| GeneOntologyBiologicalProcess | cellular anatomical entity morphogenesis | 1.81e-05 | 156 | 149 | 8 | GO:0032989 | |
| GeneOntologyBiologicalProcess | cellular component assembly involved in morphogenesis | 1.81e-05 | 156 | 149 | 8 | GO:0010927 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | NRAP COL27A1 SYNPO2L P3H4 TGFB3 TUBGCP6 SPTBN4 CLIP3 LIMK2 CEP120 MYL9 XIRP2 ARHGEF10 MTM1 MYPN PRKD1 BAIAP2 PLEC CDH5 PHLDB2 | 1.89e-05 | 957 | 149 | 20 | GO:0097435 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | KALRN SYNE1 DVL2 MGLL TSC2 SRCIN1 CPNE5 TIAM2 SPTBN4 DIP2A NEO1 PPP3CA CELSR3 MYPN BAIAP2 DMD NOTCH2 EPHA5 | 2.01e-05 | 802 | 149 | 18 | GO:0048812 |
| GeneOntologyBiologicalProcess | organelle assembly | NRAP SYNE1 SYNPO2L ABLIM3 DNAH7 DNAH1 TUBGCP6 LIMK2 CEP120 MYL9 CELSR3 WDR11 ARHGEF10 MTM1 MYPN RPF2 MTMR3 PRKD1 PLEC CDK2 TCTN2 RAB11FIP3 | 2.32e-05 | 1138 | 149 | 22 | GO:0070925 |
| GeneOntologyBiologicalProcess | cell junction organization | DOCK1 ANK2 KALRN TNC TSC2 SRCIN1 RCC2 TGFB3 SPTBN4 DIP2A JUP SRPX2 MAPK14 XIRP2 SETD5 BAIAP2 PLEC CDH5 PHLDB2 EPHA5 | 2.43e-05 | 974 | 149 | 20 | GO:0034330 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | KALRN SYNE1 DVL2 MGLL TSC2 SRCIN1 CPNE5 TIAM2 SPTBN4 DIP2A NEO1 PPP3CA CELSR3 MYPN BAIAP2 DMD NOTCH2 EPHA5 | 2.66e-05 | 819 | 149 | 18 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | KALRN SYNE1 DVL2 MGLL TSC2 SRCIN1 CPNE5 TIAM2 SPTBN4 DIP2A NEO1 PPP3CA CELSR3 MYPN BAIAP2 DMD NOTCH2 EPHA5 | 2.97e-05 | 826 | 149 | 18 | GO:0048858 |
| GeneOntologyBiologicalProcess | myofibril assembly | 3.75e-05 | 86 | 149 | 6 | GO:0030239 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | ARHGAP24 KALRN SYNE1 TSC2 SRCIN1 ADCY6 RCC2 TIAM2 TGFB3 LIMK2 NEO1 PPP2R5D PPP3CA CEP120 PRKD1 BAIAP2 DMD RAB11FIP3 | 4.06e-05 | 846 | 149 | 18 | GO:0120035 |
| GeneOntologyBiologicalProcess | neuron development | SLC4A7 KALRN TNC SYNE1 DVL2 MGLL TSC2 SRCIN1 CPNE5 ADCY6 NCDN TIAM2 SPTBN4 DIP2A NEO1 PPP2R5D PPP3CA CELSR3 CABP4 MYPN PRKD1 BAIAP2 DMD NOTCH2 EPHA5 | 4.78e-05 | 1463 | 149 | 25 | GO:0048666 |
| GeneOntologyBiologicalProcess | neuron projection development | KALRN TNC SYNE1 DVL2 MGLL TSC2 SRCIN1 CPNE5 ADCY6 NCDN TIAM2 SPTBN4 DIP2A NEO1 PPP2R5D PPP3CA CELSR3 MYPN PRKD1 BAIAP2 DMD NOTCH2 EPHA5 | 4.95e-05 | 1285 | 149 | 23 | GO:0031175 |
| GeneOntologyBiologicalProcess | actomyosin structure organization | 6.19e-05 | 239 | 149 | 9 | GO:0031032 | |
| GeneOntologyBiologicalProcess | regulation of modification of postsynaptic actin cytoskeleton | 7.75e-05 | 12 | 149 | 3 | GO:1905274 | |
| GeneOntologyBiologicalProcess | regulation of phosphate metabolic process | RAD51 RBL2 DVL2 TSC2 SRCIN1 LAX1 CDCA2 SPTBN4 CLIP3 LIMK2 SRPX2 PPP2R5D CELSR3 SOCS5 MTMR3 TNKS1BP1 PRKD1 PLEC DMD SLC4A4 CTDSPL CDH5 NOTCH2 EPHA5 | 8.29e-05 | 1421 | 149 | 24 | GO:0019220 |
| GeneOntologyBiologicalProcess | regulation of actin filament-based process | ANK2 SYNPO2L DVL2 TGFB3 SPTBN4 JUP XIRP2 ARHGEF10 PRKD1 BAIAP2 PHLDB2 EPHA5 | 8.34e-05 | 438 | 149 | 12 | GO:0032970 |
| GeneOntologyBiologicalProcess | regulation of phosphorus metabolic process | RAD51 RBL2 DVL2 TSC2 SRCIN1 LAX1 CDCA2 SPTBN4 CLIP3 LIMK2 SRPX2 PPP2R5D CELSR3 SOCS5 MTMR3 TNKS1BP1 PRKD1 PLEC DMD SLC4A4 CTDSPL CDH5 NOTCH2 EPHA5 | 8.48e-05 | 1423 | 149 | 24 | GO:0051174 |
| GeneOntologyBiologicalProcess | positive regulation of cellular component biogenesis | PIEZO1 SYNPO2L USP16 TGFB3 SRPX2 CEP120 ARHGEF10 NR1H2 PRKD1 BAIAP2 CDH5 PHLDB2 CDK2 RAB11FIP3 | 8.57e-05 | 582 | 149 | 14 | GO:0044089 |
| GeneOntologyBiologicalProcess | circulatory system development | NPR1 ARHGAP24 SLC4A7 NRAP ANK2 SH2B3 SYNE1 COL27A1 SYNPO2L DVL2 TSC2 ACVR2B TGFB3 JUP SRPX2 MAPK14 WDR11 XIRP2 MMRN2 PRKD1 PLEC CDH5 NOTCH2 EPHA5 | 1.04e-04 | 1442 | 149 | 24 | GO:0072359 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | KALRN SYNE1 MGLL TSC2 SRCIN1 TIAM2 SPTBN4 DIP2A NEO1 PPP3CA CELSR3 CABP4 MYPN BAIAP2 NOTCH2 EPHA5 | 1.05e-04 | 748 | 149 | 16 | GO:0048667 |
| GeneOntologyBiologicalProcess | actin filament-based process | NRAP ANK2 SYNPO2L DVL2 SRCIN1 TGFB3 SPTBN4 JUP LIMK2 MYL9 XIRP2 ARHGEF10 MYPN PRKD1 BAIAP2 PLEC PHLDB2 EPHA5 | 1.06e-04 | 912 | 149 | 18 | GO:0030029 |
| GeneOntologyBiologicalProcess | regulation of protein localization | KALRN SRCIN1 ABLIM3 TGFB3 CLIP3 JUP LIMK2 NEO1 MAPK14 PPP3CA CEP120 CELSR3 CSNK2A1 GLUD1 RIPOR1 NR1H2 PRKD1 GPC5 EPHA5 RAB11FIP3 | 1.11e-04 | 1087 | 149 | 20 | GO:0032880 |
| GeneOntologyBiologicalProcess | muscle cell development | 1.14e-04 | 259 | 149 | 9 | GO:0055001 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | KALRN SYNE1 PIEZO1 SYNPO2L DVL2 TSC2 TIAM2 TGFB3 CLIP3 SRPX2 MAPK14 PPP2R5D PPP3CA CEP120 ARHGEF10 NR1H2 PRKD1 BAIAP2 DMD CDH5 PHLDB2 CDK2 RAB11FIP3 | 1.24e-04 | 1366 | 149 | 23 | GO:0051130 |
| GeneOntologyBiologicalProcess | muscle structure development | DOCK1 NRAP ANK2 SYNE1 PIEZO1 SYNPO2L NEO1 MAPK14 PPP3CA MYL9 XIRP2 MTM1 MYPN PRKD1 PLEC DMD NOTCH2 | 1.59e-04 | 858 | 149 | 17 | GO:0061061 |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | AGAP5 ARHGAP24 KALRN DVL2 TSC2 RCC2 TIAM2 ARHGEF10 RIPOR1 EPHA5 | 1.66e-04 | 335 | 149 | 10 | GO:0043087 |
| GeneOntologyBiologicalProcess | myotube differentiation | 1.93e-04 | 164 | 149 | 7 | GO:0014902 | |
| GeneOntologyBiologicalProcess | regulation of phosphorylation | RAD51 RBL2 DVL2 TSC2 SRCIN1 LAX1 SPTBN4 CLIP3 LIMK2 SRPX2 PPP2R5D CELSR3 SOCS5 TNKS1BP1 PRKD1 PLEC DMD CTDSPL CDH5 NOTCH2 EPHA5 | 2.00e-04 | 1226 | 149 | 21 | GO:0042325 |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | NRAP SYNPO2L DVL2 SRCIN1 TGFB3 SPTBN4 LIMK2 MYL9 XIRP2 ARHGEF10 MYPN PRKD1 BAIAP2 PLEC PHLDB2 EPHA5 | 2.35e-04 | 803 | 149 | 16 | GO:0030036 |
| GeneOntologyBiologicalProcess | protein localization to cell periphery | ANK2 KALRN TSC2 GRIN2C ADCY6 GGA3 SPTBN4 CLIP3 JUP CSNK2A1 RAB11FIP3 | 2.55e-04 | 422 | 149 | 11 | GO:1990778 |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | SYNPO2L DVL2 TGFB3 SPTBN4 CLIP3 CEP120 XIRP2 ARHGEF10 PRKD1 BAIAP2 CDH5 PHLDB2 EPHA5 | 3.02e-04 | 579 | 149 | 13 | GO:0051493 |
| GeneOntologyBiologicalProcess | dendritic spine morphogenesis | 3.03e-04 | 81 | 149 | 5 | GO:0060997 | |
| GeneOntologyBiologicalProcess | cellular response to alcohol | 3.67e-04 | 130 | 149 | 6 | GO:0097306 | |
| GeneOntologyBiologicalProcess | regulation of establishment of protein localization | SRCIN1 ABLIM3 TGFB3 JUP NEO1 MAPK14 PPP3CA CEP120 GLUD1 RIPOR1 NR1H2 PRKD1 EPHA5 RAB11FIP3 | 3.87e-04 | 674 | 149 | 14 | GO:0070201 |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | DOCK1 SH2B3 TNC PIEZO1 TSC2 SRCIN1 SOX13 RCC2 LAX1 JUP MAPK14 PPP3CA SOCS5 BTN2A3P DMD PHLDB2 EPHA5 | 3.92e-04 | 927 | 149 | 17 | GO:0030155 |
| GeneOntologyBiologicalProcess | peptidyl-serine phosphorylation | SPTBN4 MAPK14 CSNK2A1 TNKS1BP1 PRKD1 DMD MAPK13 CSNK2A3 CDK2 | 4.03e-04 | 307 | 149 | 9 | GO:0018105 |
| GeneOntologyBiologicalProcess | positive regulation of GTPase activity | 4.06e-04 | 244 | 149 | 8 | GO:0043547 | |
| GeneOntologyBiologicalProcess | negative regulation of cell adhesion | 4.08e-04 | 375 | 149 | 10 | GO:0007162 | |
| GeneOntologyBiologicalProcess | regulation of cellular localization | KALRN SRCIN1 ABLIM3 TGFB3 CLIP3 JUP LIMK2 NEO1 MAPK14 PPP3CA CEP120 CELSR3 CSNK2A1 GLUD1 RIPOR1 NR1H2 PRKD1 GPC5 EPHA5 RAB11FIP3 | 4.63e-04 | 1212 | 149 | 20 | GO:0060341 |
| GeneOntologyBiologicalProcess | regulation of actin cytoskeleton organization | SYNPO2L DVL2 TGFB3 SPTBN4 XIRP2 ARHGEF10 PRKD1 BAIAP2 PHLDB2 EPHA5 | 4.91e-04 | 384 | 149 | 10 | GO:0032956 |
| GeneOntologyBiologicalProcess | regulation of modification of postsynaptic structure | 5.14e-04 | 22 | 149 | 3 | GO:0099159 | |
| GeneOntologyBiologicalProcess | peptidyl-serine modification | SPTBN4 MAPK14 CSNK2A1 TNKS1BP1 PRKD1 DMD MAPK13 CSNK2A3 CDK2 | 5.32e-04 | 319 | 149 | 9 | GO:0018209 |
| GeneOntologyBiologicalProcess | dendritic spine development | 5.65e-04 | 141 | 149 | 6 | GO:0060996 | |
| GeneOntologyBiologicalProcess | dendrite morphogenesis | 6.01e-04 | 198 | 149 | 7 | GO:0048813 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | SYNE1 SYNPO2L DVL2 TSC2 TGFB3 CDCA2 SPTBN4 CLIP3 LIMK2 CEP120 XIRP2 ARHGEF10 MTM1 MTMR3 PRKD1 BAIAP2 CDH5 PHLDB2 CDK2 EPHA5 RAB11FIP3 | 6.63e-04 | 1342 | 149 | 21 | GO:0033043 |
| GeneOntologyBiologicalProcess | modification of postsynaptic actin cytoskeleton | 6.69e-04 | 24 | 149 | 3 | GO:0098885 | |
| GeneOntologyBiologicalProcess | membraneless organelle assembly | NRAP SYNPO2L TUBGCP6 CEP120 MYL9 ARHGEF10 MYPN RPF2 PRKD1 PLEC CDK2 | 6.86e-04 | 475 | 149 | 11 | GO:0140694 |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | ARHGAP24 KALRN SYNPO2L TSC2 DENND3 TIAM2 ARHGEF10 RIPOR1 NOTCH2 | 7.22e-04 | 333 | 149 | 9 | GO:0051056 |
| GeneOntologyBiologicalProcess | negative regulation of pinocytosis | 7.63e-04 | 6 | 149 | 2 | GO:0048550 | |
| GeneOntologyBiologicalProcess | regulation of DNA ligation | 7.63e-04 | 6 | 149 | 2 | GO:0051105 | |
| GeneOntologyBiologicalProcess | regulation of protein transport | SRCIN1 TGFB3 JUP NEO1 MAPK14 PPP3CA GLUD1 RIPOR1 NR1H2 PRKD1 EPHA5 RAB11FIP3 | 7.77e-04 | 560 | 149 | 12 | GO:0051223 |
| GeneOntologyBiologicalProcess | sarcomere organization | 8.74e-04 | 59 | 149 | 4 | GO:0045214 | |
| GeneOntologyBiologicalProcess | regulation of system process | NPR1 ANK2 SYNE1 MGLL GRIN2C SLC4A3 SPTBN4 JUP PPP3CA MYL9 NR1H2 PRKD1 BAIAP2 DMD | 8.93e-04 | 734 | 149 | 14 | GO:0044057 |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | KALRN DVL2 TSC2 TIAM2 TGFB3 PPP2R5D CEP120 PRKD1 BAIAP2 DMD RAB11FIP3 | 9.45e-04 | 494 | 149 | 11 | GO:0031346 |
| GeneOntologyCellularComponent | I band | NRAP ANK2 SYNPO2L JUP PPP3CA MYL9 XIRP2 MTM1 MYPN PRKD1 PLEC DMD | 3.04e-09 | 166 | 151 | 12 | GO:0031674 |
| GeneOntologyCellularComponent | Z disc | 1.31e-08 | 151 | 151 | 11 | GO:0030018 | |
| GeneOntologyCellularComponent | sarcomere | NRAP ANK2 SYNE1 SYNPO2L JUP PPP3CA MYL9 XIRP2 MTM1 MYPN PRKD1 PLEC DMD | 3.32e-08 | 249 | 151 | 13 | GO:0030017 |
| GeneOntologyCellularComponent | myofibril | NRAP ANK2 SYNE1 SYNPO2L JUP PPP3CA MYL9 XIRP2 MTM1 MYPN PRKD1 PLEC DMD | 9.74e-08 | 273 | 151 | 13 | GO:0030016 |
| GeneOntologyCellularComponent | contractile muscle fiber | NRAP ANK2 SYNE1 SYNPO2L JUP PPP3CA MYL9 XIRP2 MTM1 MYPN PRKD1 PLEC DMD | 1.96e-07 | 290 | 151 | 13 | GO:0043292 |
| GeneOntologyCellularComponent | supramolecular fiber | NRAP ANK2 SYNE1 COL27A1 SYNPO2L DNAH7 RCC2 DNAH1 TUBGCP6 SPTBN4 CLIP3 PARP4 JUP PPP3CA MYL9 XIRP2 MTM1 MYPN PRKD1 BAIAP2 PLEC DMD | 4.00e-05 | 1179 | 151 | 22 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | NRAP ANK2 SYNE1 COL27A1 SYNPO2L DNAH7 RCC2 DNAH1 TUBGCP6 SPTBN4 CLIP3 PARP4 JUP PPP3CA MYL9 XIRP2 MTM1 MYPN PRKD1 BAIAP2 PLEC DMD | 4.43e-05 | 1187 | 151 | 22 | GO:0099081 |
| GeneOntologyCellularComponent | U2-type post-mRNA release spliceosomal complex | 1.55e-04 | 3 | 151 | 2 | GO:0071008 | |
| GeneOntologyCellularComponent | protein kinase CK2 complex | 3.08e-04 | 4 | 151 | 2 | GO:0005956 | |
| GeneOntologyCellularComponent | costamere | 5.14e-04 | 22 | 151 | 3 | GO:0043034 | |
| GeneOntologyCellularComponent | anchoring junction | ARHGAP24 NRAP ANK2 TNC SRCIN1 SPTBN4 JUP PPP3CA XIRP2 TNKS1BP1 PRKD1 BAIAP2 PLEC DMD CDH5 PHLDB2 EPHA5 | 7.03e-04 | 976 | 151 | 17 | GO:0070161 |
| GeneOntologyCellularComponent | adherens junction | 8.99e-04 | 212 | 151 | 7 | GO:0005912 | |
| GeneOntologyCellularComponent | extrinsic component of membrane | 1.44e-03 | 230 | 151 | 7 | GO:0019898 | |
| GeneOntologyCellularComponent | intercalated disc | 1.49e-03 | 68 | 151 | 4 | GO:0014704 | |
| MousePheno | abnormal intercalated disk morphology | 1.49e-05 | 18 | 121 | 4 | MP:0006267 | |
| Domain | Spectrin_repeat | 3.18e-06 | 29 | 150 | 5 | IPR002017 | |
| Domain | SPEC | 5.28e-06 | 32 | 150 | 5 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 5.28e-06 | 32 | 150 | 5 | IPR018159 | |
| Domain | Spectrin | 3.14e-05 | 23 | 150 | 4 | PF00435 | |
| Domain | ACTININ_2 | 3.14e-05 | 23 | 150 | 4 | PS00020 | |
| Domain | ACTININ_1 | 3.14e-05 | 23 | 150 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 3.14e-05 | 23 | 150 | 4 | IPR001589 | |
| Domain | - | 4.12e-05 | 9 | 150 | 3 | 3.40.1100.10 | |
| Domain | Band3_cytoplasmic_dom | 4.12e-05 | 9 | 150 | 3 | IPR013769 | |
| Domain | Band_3_cyto | 4.12e-05 | 9 | 150 | 3 | PF07565 | |
| Domain | PTrfase/Anion_transptr | 5.85e-05 | 10 | 150 | 3 | IPR016152 | |
| Domain | HCO3_transpt_euk | 5.85e-05 | 10 | 150 | 3 | IPR003020 | |
| Domain | HCO3_cotransp | 5.85e-05 | 10 | 150 | 3 | PF00955 | |
| Domain | HCO3_transpt_C | 5.85e-05 | 10 | 150 | 3 | IPR011531 | |
| Domain | Tankyrase-bd_C | 6.41e-05 | 2 | 150 | 2 | IPR032764 | |
| Domain | Tankyrase_bdg_C | 6.41e-05 | 2 | 150 | 2 | SM01319 | |
| Domain | Tankyrase_bdg_C | 6.41e-05 | 2 | 150 | 2 | PF15327 | |
| Domain | ARM-type_fold | DOCK1 INTS7 TSC2 ARMCX5 NCDN RANBP17 JUP PPP2R5D PIK3C2B UTP20 RIPOR1 | 9.46e-05 | 339 | 150 | 11 | IPR016024 |
| Domain | Kinase-like_dom | NPR1 KALRN ACVR2B TXK LIMK2 MAPK14 PIK3C2B CSNK2A1 PRKD1 DMD MAPK13 CSNK2A3 CDK2 EPHA5 | 1.23e-04 | 542 | 150 | 14 | IPR011009 |
| Domain | PH_dom-like | AGAP5 ARHGAP24 SH2B3 KALRN TIAM2 SPTBN4 ARHGEF10 PLCH2 MTM1 MTMR3 PRKD1 PHLDB2 | 1.72e-04 | 426 | 150 | 12 | IPR011993 |
| Domain | - | AGAP5 ARHGAP24 SH2B3 KALRN TIAM2 SPTBN4 PLCH2 MTM1 MTMR3 PRKD1 PHLDB2 | 3.26e-04 | 391 | 150 | 11 | 2.30.29.30 |
| Domain | MAPK_p38 | 3.80e-04 | 4 | 150 | 2 | IPR008352 | |
| Domain | PH | 4.20e-04 | 278 | 150 | 9 | SM00233 | |
| Domain | PH_DOMAIN | 4.31e-04 | 279 | 150 | 9 | PS50003 | |
| Domain | PH_domain | 4.43e-04 | 280 | 150 | 9 | IPR001849 | |
| Domain | PH | 5.35e-04 | 229 | 150 | 8 | PF00169 | |
| Domain | Prot_kinase_dom | NPR1 KALRN ACVR2B TXK LIMK2 MAPK14 CSNK2A1 PRKD1 MAPK13 CSNK2A3 CDK2 EPHA5 | 5.97e-04 | 489 | 150 | 12 | IPR000719 |
| Domain | Anion_exchange | 6.31e-04 | 5 | 150 | 2 | IPR001717 | |
| Domain | PROTEIN_KINASE_DOM | NPR1 KALRN ACVR2B TXK LIMK2 MAPK14 CSNK2A1 PRKD1 MAPK13 CSNK2A3 CDK2 EPHA5 | 6.41e-04 | 493 | 150 | 12 | PS50011 |
| Domain | Protein_kinase_ATP_BS | KALRN TXK LIMK2 MAPK14 CSNK2A1 PRKD1 MAPK13 CSNK2A3 CDK2 EPHA5 | 9.94e-04 | 379 | 150 | 10 | IPR017441 |
| Domain | PROTEIN_KINASE_ATP | KALRN ACVR2B TXK LIMK2 MAPK14 CSNK2A1 PRKD1 MAPK13 CSNK2A3 CDK2 EPHA5 | 1.22e-03 | 459 | 150 | 11 | PS00107 |
| Domain | ANION_EXCHANGER_2 | 1.31e-03 | 7 | 150 | 2 | PS00220 | |
| Domain | ANION_EXCHANGER_1 | 1.31e-03 | 7 | 150 | 2 | PS00219 | |
| Pathway | WP_THERMOGENESIS | 3.72e-05 | 108 | 120 | 7 | M39746 | |
| Pathway | REACTOME_BICARBONATE_TRANSPORTERS | 6.91e-05 | 10 | 120 | 3 | M27335 | |
| Pathway | REACTOME_BICARBONATE_TRANSPORTERS | 6.91e-05 | 10 | 120 | 3 | MM15073 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | DOCK1 CPNE8 ARHGAP24 SLC4A7 KALRN DVL2 RCC2 TIAM2 JUP MAPK14 PPP2R5D MYL9 WDR11 ARHGEF10 BAIAP2 SPEN | 1.21e-04 | 649 | 120 | 16 | MM15690 |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | DOCK1 CPNE8 ARHGAP24 SLC4A7 KALRN DVL2 RCC2 TIAM2 JUP LIMK2 MAPK14 PPP2R5D MYL9 WDR11 ARHGEF10 BAIAP2 SPEN | 1.24e-04 | 720 | 120 | 17 | M41838 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DOCK1 PLCXD1 TMEM63B MGLL SRCIN1 ACVR2B NCDN DNAH1 KIAA1671 SPTBN4 RANBP17 ANKRD44 PPP2R2C PPP3CA SUGP2 WDR11 SETD5 ASMTL RPF2 EXOC6B RIPOR1 PRKD1 BAIAP2 CTDSPL NOTCH2 | 6.59e-09 | 1489 | 151 | 25 | 28611215 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | RAD51 SH2B3 KALRN PIEZO1 TSC2 TIAM2 GGA3 DIP2A CELSR3 SUGP2 SLC45A3 PIK3C2B SETD5 PPA2 MTMR3 RIPOR1 TNKS1BP1 PLEC SPEN NOTCH2 RAB11FIP3 | 1.51e-08 | 1105 | 151 | 21 | 35748872 |
| Pubmed | MKRN3 ANK2 KALRN RBL2 SYNE1 TFIP11 TSC2 CPNE5 USP16 SLC4A3 SPTBN4 VPS9D1 DIP2A PPP3CA CELSR3 ARHGEF10 MTM1 GLUD1 MTMR3 NR1H2 BAIAP2 PLEC | 4.21e-08 | 1285 | 151 | 22 | 35914814 | |
| Pubmed | CPNE8 SLC4A7 DDX31 ANK2 SYNE1 PIEZO1 COPE TFIP11 USP16 NCDN TUBGCP6 DIP2A JUP NEO1 PPP2R5D WDR11 ARHGEF10 GLUD1 RPF2 PPA2 TTC13 BAIAP2 NOTCH2 | 1.25e-07 | 1487 | 151 | 23 | 33957083 | |
| Pubmed | DDX31 COPE DUSP4 KIAA1671 CDCA2 MAPK14 PPP2R5D PPP3CA FBXO3 WDR11 CSNK2A1 MTM1 MTMR3 AATF BAIAP2 DMD CTDSPL CPSF3 | 7.70e-07 | 1049 | 151 | 18 | 27880917 | |
| Pubmed | ANK2 KALRN TNC SYNE1 SRCIN1 ABLIM3 NCDN DHX15 SPTBN4 DIP2A JUP PPP2R2C PPP3CA SUGP2 CSNK2A1 GLUD1 TNKS1BP1 BAIAP2 PLEC DMD SLC4A4 | 1.09e-06 | 1431 | 151 | 21 | 37142655 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 1.24e-06 | 313 | 151 | 10 | 38270169 | |
| Pubmed | NRAP ANK2 KALRN SYNE1 DHX15 PARP4 NEO1 XIRP2 AGL MYPN PLEC NOTCH2 | 1.98e-06 | 497 | 151 | 12 | 23414517 | |
| Pubmed | The C-terminal regulatory domain of p53 contains a functional docking site for cyclin A. | 4.42e-06 | 8 | 151 | 3 | 10884347 | |
| Pubmed | ARHGAP24 ANK2 KALRN SYNE1 DVL2 TSC2 ABLIM3 NCDN SPTBN4 PPP2R5D PPP3CA CSNK2A1 PRKD1 BAIAP2 SLC4A4 PHLDB2 | 4.95e-06 | 963 | 151 | 16 | 28671696 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | RAD51 PRPSAP2 COPE DVL2 RCC2 NCDN DHX15 JUP MAPK14 PPP2R5D PPP3CA MYL9 ARHGEF10 ASMTL CSNK2A1 AGL RIPOR1 TNKS1BP1 PLEC HERC4 | 5.35e-06 | 1455 | 151 | 20 | 22863883 |
| Pubmed | CPNE8 FAM234A ARHGAP24 NRAP INTS7 COPE TFIP11 ABLIM3 LIMK2 FBXO3 SOCS5 MYPN PPA2 EPHA5 | 5.43e-06 | 750 | 151 | 14 | 11230166 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TFIP11 USP16 ADCY6 TUBGCP6 SUGP2 CSNK2A1 UTP20 RIPOR1 TNKS1BP1 PLEC SPEN NOTCH2 PHLDB2 CDK2 | 7.75e-06 | 774 | 151 | 14 | 15302935 |
| Pubmed | CPNE8 FAM234A NRAP INTS7 COPE TFIP11 ABLIM3 LIMK2 PPP3CA MYPN PPA2 DMD CDK2 EPHA5 | 1.03e-05 | 794 | 151 | 14 | 11076863 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | CPNE8 SYNE1 RCC2 NCDN DHX15 KIAA1671 JUP SUGP2 CSNK2A1 GLUD1 RPF2 UTP20 AATF PLEC SPEN PHLDB2 | 1.06e-05 | 1024 | 151 | 16 | 24711643 |
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | 1.64e-05 | 420 | 151 | 10 | 28065597 | |
| Pubmed | CPNE8 FAM234A NRAP INTS7 COPE TFIP11 ABLIM3 LIMK2 PPP3CA MYPN PPA2 CDK2 EPHA5 | 1.69e-05 | 720 | 151 | 13 | 16381901 | |
| Pubmed | CPNE8 FAM234A NRAP INTS7 COPE TFIP11 ABLIM3 LIMK2 PPP3CA MYPN PPA2 CDK2 EPHA5 | 1.74e-05 | 722 | 151 | 13 | 15489336 | |
| Pubmed | Some human KIR haplotypes contain two KIR2DL5 genes: KIR2DL5A and KIR2DL5B. | 1.87e-05 | 2 | 151 | 2 | 12185535 | |
| Pubmed | Role of an extracellular loop in determining the stoichiometry of Na+-HCO₃⁻ cotransporters. | 1.87e-05 | 2 | 151 | 2 | 21224233 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 10727080 | ||
| Pubmed | Gene structure and promoter variation of expressed and nonexpressed variants of the KIR2DL5 gene. | 1.87e-05 | 2 | 151 | 2 | 11086080 | |
| Pubmed | Three-dimensional atomic structure of a catalytic subunit mutant of human protein kinase CK2. | 1.87e-05 | 2 | 151 | 2 | 14646071 | |
| Pubmed | Stimulation of calcineurin Aalpha activity attenuates muscle pathophysiology in mdx dystrophic mice. | 1.87e-05 | 2 | 151 | 2 | 18199592 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 28429785 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 30359423 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 27554968 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 16793906 | ||
| Pubmed | Crystal structure of a C-terminal deletion mutant of human protein kinase CK2 catalytic subunit. | 1.87e-05 | 2 | 151 | 2 | 12860116 | |
| Pubmed | Molecular cloning and characterization of a novel p38 mitogen-activated protein kinase. | 1.87e-05 | 2 | 151 | 2 | 9295308 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 9188854 | ||
| Pubmed | Association of KIR2DL5B gene with celiac disease supports the susceptibility locus on 19q13.4. | 1.87e-05 | 2 | 151 | 2 | 17215859 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 19539422 | ||
| Pubmed | p38α blocks brown adipose tissue thermogenesis through p38δ inhibition. | 1.87e-05 | 2 | 151 | 2 | 29979672 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 38491008 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 31186359 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 19706521 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 30258108 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 22783023 | ||
| Pubmed | TFIP11 interacts with mDEAH9, an RNA helicase involved in spliceosome disassembly. | 1.87e-05 | 2 | 151 | 2 | 19165350 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 21281811 | ||
| Pubmed | The Na+/HCO3- co-transporter is protective during ischemia in astrocytes. | 1.87e-05 | 2 | 151 | 2 | 27717805 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 37356621 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 23192621 | ||
| Pubmed | Mapping non-class II H2-linked loci for type 1 diabetes in nonobese diabetic mice. | 1.87e-05 | 2 | 151 | 2 | 15561967 | |
| Pubmed | Assignment of casein kinase 2 alpha sequences to two different human chromosomes. | 1.87e-05 | 2 | 151 | 2 | 1577469 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 22383045 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 7528718 | ||
| Pubmed | Molecular cloning of the human casein kinase II alpha subunit. | 1.87e-05 | 2 | 151 | 2 | 2752008 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 10900271 | ||
| Pubmed | Structure and sequence of an intronless gene for human casein kinase II-alpha subunit. | 1.87e-05 | 2 | 151 | 2 | 8420794 | |
| Pubmed | Isolation and characterization of post-splicing lariat-intron complexes. | 1.87e-05 | 2 | 151 | 2 | 19103666 | |
| Pubmed | NBC3 expression in rabbit collecting duct: colocalization with vacuolar H+-ATPase. | 1.87e-05 | 2 | 151 | 2 | 10600945 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 29287762 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 32407333 | ||
| Pubmed | DUSP4 CPNE5 MAPK14 SETD5 CSNK2A1 CABP4 MTM1 PPA2 MTMR3 ECEL1 KLHL12 MAPK13 CDK2 | 1.95e-05 | 730 | 151 | 13 | 34857952 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | KALRN SYNE1 ARRDC5 COPE TFIP11 RCC2 DHX15 FBXO3 SUGP2 CSNK2A1 RPF2 TNKS1BP1 PLEC SLC25A19 SPEN CPSF3 | 2.08e-05 | 1082 | 151 | 16 | 38697112 |
| Pubmed | AGAP5 PIEZO1 SRCIN1 RCC2 TIAM2 GGA3 TUBGCP6 CELSR3 PLCH2 TNKS1BP1 HERC4 | 2.15e-05 | 529 | 151 | 11 | 14621295 | |
| Pubmed | 2.22e-05 | 13 | 151 | 3 | 19120281 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | SLC4A7 TSC2 DNAH7 KIAA1671 CDCA2 JUP LIMK2 PIK3C2B ARHGEF10 TNKS1BP1 BAIAP2 PLEC NOTCH2 PHLDB2 | 2.52e-05 | 861 | 151 | 14 | 36931259 |
| Pubmed | GALK1 PLCXD1 DVL2 ADCY6 P3H4 KIAA1671 TUBGCP6 LIMK2 SUGP2 SETD5 CSNK2A1 SLC25A19 NOTCH2 PHLDB2 TCTN2 SP140 | 3.02e-05 | 1116 | 151 | 16 | 31753913 | |
| Pubmed | DDX31 RCC2 DHX15 SUGP2 CSNK2A1 RPF2 UTP20 AATF TNKS1BP1 PLEC SPEN CPSF3 | 3.04e-05 | 653 | 151 | 12 | 22586326 | |
| Pubmed | TRIM65 regulates microRNA activity by ubiquitination of TNRC6. | 3.27e-05 | 364 | 151 | 9 | 24778252 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 3.37e-05 | 281 | 151 | 8 | 28706196 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | CPNE8 USP16 RCC2 DHX15 KIAA1671 JUP WDR11 CSNK2A1 GLUD1 RPF2 UTP20 AATF TNKS1BP1 BAIAP2 PLEC SPEN PHLDB2 | 3.51e-05 | 1257 | 151 | 17 | 36526897 |
| Pubmed | SLC4A7 COPE DNAH7 KIAA1671 CDCA2 NEO1 PPP3CA SUGP2 WDR11 BAIAP2 SLC25A19 SPEN NOTCH2 | 3.71e-05 | 777 | 151 | 13 | 35844135 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | SLC4A7 SRCIN1 ABLIM3 GGA3 KIAA1671 JUP TNKS1BP1 BAIAP2 PLEC NOTCH2 PHLDB2 | 3.91e-05 | 565 | 151 | 11 | 25468996 |
| Pubmed | [Polymorphism of killer cell immunoglobulin-like receptors gene family in Zhejiang Han population]. | 4.31e-05 | 16 | 151 | 3 | 16403292 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | PRPSAP2 SLC4A7 INTS7 COPE TFIP11 TSC2 RCC2 NCDN DHX15 JUP PPP2R5D FBXO3 CSNK2A1 AGL GLUD1 TNKS1BP1 PLEC CDK2 | 4.52e-05 | 1415 | 151 | 18 | 28515276 |
| Pubmed | PRPSAP2 P3H4 DHX15 JUP PPP2R5D PPP3CA MYL9 FBXO3 CSNK2A1 PPA2 TNKS1BP1 ECEL1 TTC13 HERC4 CPSF3 NOTCH2 CDK2 | 5.17e-05 | 1297 | 151 | 17 | 33545068 | |
| Pubmed | SCF (Fbxl17) ubiquitylation of Sufu regulates Hedgehog signaling and medulloblastoma development. | 5.22e-05 | 17 | 151 | 3 | 27234298 | |
| Pubmed | Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection. | 5.22e-05 | 17 | 151 | 3 | 20878400 | |
| Pubmed | 5.22e-05 | 17 | 151 | 3 | 20650299 | ||
| Pubmed | [Analysis of natural killer cell immunoglobulin-like receptor genes in Chinese]. | 5.22e-05 | 17 | 151 | 3 | 19218127 | |
| Pubmed | 5.22e-05 | 17 | 151 | 3 | 19450876 | ||
| Pubmed | 5.22e-05 | 17 | 151 | 3 | 19761533 | ||
| Pubmed | PIP30/FAM192A is a novel regulator of the nuclear proteasome activator PA28γ. | 5.27e-05 | 47 | 151 | 4 | 29934401 | |
| Pubmed | 5.38e-05 | 151 | 151 | 6 | 17043677 | ||
| Pubmed | Activation of pre-mRNA splicing by human RNPS1 is regulated by CK2 phosphorylation. | 5.60e-05 | 3 | 151 | 2 | 15684395 | |
| Pubmed | Tenascin-C is a novel RBPJkappa-induced target gene for Notch signaling in gliomas. | 5.60e-05 | 3 | 151 | 2 | 19147558 | |
| Pubmed | Killer-cell immunoglobulin-like receptors and falciparum malaria in southwest Nigeria. | 5.60e-05 | 3 | 151 | 2 | 24929143 | |
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 9739078 | ||
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 2174700 | ||
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 31586031 | ||
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 24726641 | ||
| Pubmed | Strong induction of the Tis11B gene in myogenic differentiation. | 5.60e-05 | 3 | 151 | 2 | 17889962 | |
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 19015309 | ||
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 1766873 | ||
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 24268649 | ||
| Pubmed | Calcineurin enhances MAPK phosphatase-1 expression and p38 MAPK inactivation in cardiac myocytes. | 5.60e-05 | 3 | 151 | 2 | 11279073 | |
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 37758009 | ||
| Pubmed | Crystallization and preliminary characterization of crystals of human protein kinase CK2. | 5.60e-05 | 3 | 151 | 2 | 11092945 | |
| Pubmed | Regulation of CD163 associated casein kinase II activity is haptoglobin genotype dependent. | 5.60e-05 | 3 | 151 | 2 | 18563533 | |
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 21336470 | ||
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 12102635 | ||
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 22841819 | ||
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 35509083 | ||
| Pubmed | Functional polymorphism of the CK2alpha intronless gene plays oncogenic roles in lung cancer. | 5.60e-05 | 3 | 151 | 2 | 20625391 | |
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 33633112 | ||
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 32316696 | ||
| Interaction | VCL interactions | ARHGAP24 GALK1 NRAP RCC2 FBXO30 GGA3 KIAA1671 JUP AGL TNKS1BP1 CDH5 CDK2 | 3.12e-06 | 305 | 150 | 12 | int:VCL |
| GeneFamily | CD molecules|Killer cell immunoglobulin like receptors | 1.72e-04 | 18 | 111 | 3 | 620 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.81e-04 | 206 | 111 | 7 | 682 | |
| GeneFamily | LIM domain containing | 4.72e-04 | 59 | 111 | 4 | 1218 | |
| GeneFamily | Copines | 1.31e-03 | 9 | 111 | 2 | 829 | |
| GeneFamily | Mitogen-activated protein kinases | 2.79e-03 | 13 | 111 | 2 | 651 | |
| GeneFamily | ATP binding cassette subfamily A | 3.24e-03 | 14 | 111 | 2 | 805 | |
| GeneFamily | WD repeat domain containing|Protein phosphatase 2 regulatory subunits | 3.72e-03 | 15 | 111 | 2 | 696 | |
| GeneFamily | Myotubularins|Phosphoinositide phosphatases | 3.72e-03 | 15 | 111 | 2 | 903 | |
| GeneFamily | Dyneins, axonemal | 4.78e-03 | 17 | 111 | 2 | 536 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_MEGAKARYOCYTE | FAM234A KALRN SLC44A2 TMEM63B MGLL CPNE5 ABLIM3 CRAT ADCY6 MYL9 XIRP2 DENND2C CTDSPL CDK2 RAB11FIP3 | 1.13e-05 | 694 | 150 | 15 | M45731 |
| Coexpression | GSE32533_WT_VS_MIR17_OVEREXPRESS_ACT_CD4_TCELL_UP | 2.01e-05 | 199 | 150 | 8 | M8462 | |
| Coexpression | HALLMARK_APICAL_JUNCTION | 2.08e-05 | 200 | 150 | 8 | M5915 | |
| Coexpression | NUYTTEN_EZH2_TARGETS_UP | THEMIS2 CPNE8 TNC SYNE1 SLC44A2 TMEM63B MGLL DENND3 TGFB3 SRPX2 SUGP2 SOCS5 TNKS1BP1 TTC13 BAIAP2 SLC4A4 PHLDB2 SP140 | 2.69e-05 | 1033 | 150 | 18 | M4196 |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | DOCK1 CPNE8 SYNE1 ABLIM3 SOX13 ABCA9 RANBP17 SRPX2 PRKD1 CDH5 | 1.44e-09 | 200 | 148 | 10 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | DOCK1 CPNE8 SYNE1 ABLIM3 SOX13 ABCA9 RANBP17 SRPX2 PRKD1 CDH5 | 1.44e-09 | 200 | 148 | 10 | 68fce28690246895fd33354b30960ebcc31aa4cc |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | DOCK1 CPNE8 SYNE1 ABLIM3 SOX13 ABCA9 RANBP17 SRPX2 PRKD1 CDH5 | 1.44e-09 | 200 | 148 | 10 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | DOCK1 CPNE8 SYNE1 ABLIM3 SOX13 ABCA9 RANBP17 SRPX2 PRKD1 CDH5 | 1.44e-09 | 200 | 148 | 10 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | DOCK1 CPNE8 SYNE1 ABLIM3 SOX13 ABCA9 RANBP17 SRPX2 PRKD1 CDH5 | 1.44e-09 | 200 | 148 | 10 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | DOCK1 CPNE8 SYNE1 ABLIM3 SOX13 ABCA9 RANBP17 SRPX2 PRKD1 CDH5 | 1.44e-09 | 200 | 148 | 10 | 7136936d05ab344a560cf159684c881063b5430d |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.42e-08 | 188 | 148 | 9 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_immature-endo_immature_arterial2_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.56e-08 | 190 | 148 | 9 | 7ba2be2630183df86de21689289a8620a4cd507e | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 2.04e-08 | 196 | 148 | 9 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.14e-08 | 197 | 148 | 9 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_immature-endo_immature_arterial2_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.20e-07 | 187 | 148 | 8 | 29b2e2be26a9d72b154760e47acf61cfe2f45fa7 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 2.38e-07 | 189 | 148 | 8 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 2.48e-07 | 190 | 148 | 8 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_mature-endo_arterial_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.48e-07 | 190 | 148 | 8 | 1307688255a1250fa300edf2c41f1affe31dcc98 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-07 | 192 | 148 | 8 | 4bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 2.91e-07 | 194 | 148 | 8 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | facs-Lung-nan-3m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-07 | 195 | 148 | 8 | 7f9b7f15006610ad591063d90e90367bd6083c7f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.40e-07 | 198 | 148 | 8 | a860246bcea847249a78fd2e86ed8e04371060db | |
| ToppCell | Macroglial-Astrocytes-SLC14A1---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.67e-07 | 200 | 148 | 8 | d6fcbf4f4bc1b89a9929d7b114c6b907b6979900 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.67e-07 | 200 | 148 | 8 | f861509b54185d89931db64da1b9d81986cc7938 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.67e-07 | 200 | 148 | 8 | 07d942803360e1a1e8e131d6e31c726dd0db1a0b | |
| ToppCell | Macroglial-Astrocytes-SLC14A1|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.67e-07 | 200 | 148 | 8 | 16f468217427921fa18c6d078ffa990eb019b257 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.67e-07 | 200 | 148 | 8 | 0442894c39eec69850c090957a5dc7bcecd21e04 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.67e-07 | 200 | 148 | 8 | 01819446deeab9054f5cfe889d53bb49d137dbc0 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 3.67e-07 | 200 | 148 | 8 | 5c7263c862093ad9dbc81d06b16b6f74e8a6b634 | |
| ToppCell | AT1-AT2_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.20e-06 | 162 | 148 | 7 | 57d627259d27f39885bf416d74bcb6656db6e27b | |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.52e-06 | 181 | 148 | 7 | ab66a89f316b935d9ba1277426d976b1e9e39757 | |
| ToppCell | COVID-19-Heart-CM_4|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.71e-06 | 183 | 148 | 7 | 2902b6e8aa9a6f62bc1a792c971ab7f651a8e676 | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-MK-MK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.71e-06 | 183 | 148 | 7 | 6cbc88c27dc957d182526e84824f70c8e860bf74 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-06 | 184 | 148 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-06 | 184 | 148 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-06 | 184 | 148 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.81e-06 | 184 | 148 | 7 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.91e-06 | 185 | 148 | 7 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.12e-06 | 187 | 148 | 7 | dd1d91f101b837bba513f77defa6e6902b2c0570 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.12e-06 | 187 | 148 | 7 | ae90c263f80c36a410150d499e268d198944a3d9 | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.12e-06 | 187 | 148 | 7 | 34cad5ac8602fe88ca3d421257190c9a388d4cb0 | |
| ToppCell | wk_08-11-Endothelial-Blood_vessel_endothelial-GRIA2+_arterial_endo|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.12e-06 | 187 | 148 | 7 | a27aa97aa6508a3ffe92c2b6bb0511a95650a390 | |
| ToppCell | droplet-Fat-SCAT-30m-Endothelial-Cd36+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-06 | 188 | 148 | 7 | e901a9bdf00b8e91806f445af66647373bf62661 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_immature-endo_immature_arterial2_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.23e-06 | 188 | 148 | 7 | b66f1f08827dd6c48583d871f9f33ea41e48bfb2 | |
| ToppCell | droplet-Fat-SCAT-30m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-06 | 188 | 148 | 7 | 5cf060bb8adaefa9964187195d67993c1248ef47 | |
| ToppCell | droplet-Lung-nan-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-06 | 188 | 148 | 7 | 405efea75233ecf70f7d19b630230798d817b7f2 | |
| ToppCell | droplet-Fat-SCAT-30m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-06 | 188 | 148 | 7 | 449f9602df3c83b2110eb479a00d428d1b55b423 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-06 | 189 | 148 | 7 | e758b264c0a47127e33e66c395cf5a3224c7305b | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-06 | 189 | 148 | 7 | b98f60875b1a12b2ec9dc91889298ae57f98602f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.47e-06 | 190 | 148 | 7 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.47e-06 | 190 | 148 | 7 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 3.59e-06 | 191 | 148 | 7 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.59e-06 | 191 | 148 | 7 | 7edc22e7e70697fb22690699efb352577162709b | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-MK-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.72e-06 | 192 | 148 | 7 | b877d14be9d04ab0010e340909e3a23de92613db | |
| ToppCell | Megakaryocytic-erythropoietic-Megakaryo-cells-Megakaryocyte|World / Lineage, cell class and subclass | 3.85e-06 | 193 | 148 | 7 | 352cd442b6e62f09b6d22a139774067873644594 | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_mature|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.98e-06 | 194 | 148 | 7 | 8c88a0ddd61ad900426e312ca4ab13061c0380b8 | |
| ToppCell | RV-09._Endothelium_I|RV / Chamber and Cluster_Paper | 3.98e-06 | 194 | 148 | 7 | 7b408096e717f2327c12aea35a8d5fc4621d3b06 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-06 | 194 | 148 | 7 | f159ef8541d75a4e98468947f231bb463bec922c | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 3.98e-06 | 194 | 148 | 7 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | TCGA-Blood_and_Bone_Marrow-Primary_Tumor-Diffuse_large_B-cell_lymphoma-DLBCL-1|TCGA-Blood_and_Bone_Marrow / Sample_Type by Project: Shred V9 | 3.98e-06 | 194 | 148 | 7 | eaeeb84576270cc3fc59002ba33bff9639bb0b02 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.98e-06 | 194 | 148 | 7 | 216cba1a04b1a24b080322bc950e7fa2dade5ff1 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.12e-06 | 195 | 148 | 7 | 2514c1f23424b5fc664d326d31ffd22bafe74ef8 | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_mature|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.12e-06 | 195 | 148 | 7 | 54fde2cfa51ab3a2d48d2426494ca6f0ce77f725 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.12e-06 | 195 | 148 | 7 | e5f14f6015ea5e6fa065f906ad22157e3de15c68 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-MK-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.26e-06 | 196 | 148 | 7 | 66ba31b74953726e9c314f6d8fe3f75d3762e23a | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.26e-06 | 196 | 148 | 7 | 481d79bdaec069ad2746a28d39eeee8d3edf7305 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.26e-06 | 196 | 148 | 7 | 256fe9bc0815f66a9afe11ba3507ef1372b52fd3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.40e-06 | 197 | 148 | 7 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.40e-06 | 197 | 148 | 7 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | LV-09._Endothelium_I|LV / Chamber and Cluster_Paper | 4.40e-06 | 197 | 148 | 7 | f9731d4d636e51b94a96805eee6afe9aedc175e3 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 4.55e-06 | 198 | 148 | 7 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.70e-06 | 199 | 148 | 7 | 85bb28369e0568b7b3bda095722102fc793f60ef | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 4.86e-06 | 200 | 148 | 7 | 61d7dd0a78942b069c3f5e75044368dc00e6e8e6 | |
| ToppCell | Macroglial-Astrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.86e-06 | 200 | 148 | 7 | 941536b7c32f1e63c70535233b2ccce0cd7bf96e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.86e-06 | 200 | 148 | 7 | 7a8160e6477708f22e48c609bf8f43f3715dcb03 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.86e-06 | 200 | 148 | 7 | d0812817ef99608994193787a62d39adeb2070ca | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Artery|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.86e-06 | 200 | 148 | 7 | 77ae679c35d3b9e2b620f34129f3a8d47e922c65 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Artery|Control_saline / Treatment groups by lineage, cell group, cell type | 4.86e-06 | 200 | 148 | 7 | 65b71f1e8da5c3750fcd0a2e66d9ef3125a3f78a | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Artery|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.86e-06 | 200 | 148 | 7 | ac9ead34afa14067171833f5c277eaf06db7b02e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.86e-06 | 200 | 148 | 7 | cd54ddf1919c98e84b7e4aba85b374fc8b407206 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Artery|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.86e-06 | 200 | 148 | 7 | b1ff8d61b567f85006d6d20093f9c803b6d34674 | |
| ToppCell | COVID-19-COVID-19_Convalescent-Others|COVID-19_Convalescent / Disease, condition lineage and cell class | 4.86e-06 | 200 | 148 | 7 | d09225512a95bc335056275204d1455b8306e7fc | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-05 | 151 | 148 | 6 | f41c6558a5874b6464c157027fdf202257c60e5b | |
| ToppCell | control-Epithelial-Ionocyte|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.90e-05 | 165 | 148 | 6 | 5cfba9a46bd8ceeca74a6493057b4d38af6b06fe | |
| ToppCell | control-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.11e-05 | 168 | 148 | 6 | 327b02f19f4a8607c033203824fdc60a1254331f | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.11e-05 | 168 | 148 | 6 | c7021748003e5949f7caf7b3291c5bad294948c1 | |
| ToppCell | mild_COVID-19_(asymptomatic)-RBC|World / disease group, cell group and cell class (v2) | 2.18e-05 | 169 | 148 | 6 | 2bda6ab3f32e05cb7daf91eb7c39b4fcc9ae91bb | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Microglia/Mac|Myeloid_cells / Location, Cell class and cell subclass | 2.18e-05 | 169 | 148 | 6 | dba8f5599aa21feef5b7fdfed2e3ab54748d80f7 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.25e-05 | 170 | 148 | 6 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.25e-05 | 170 | 148 | 6 | 09bcbc7eb3b1d35cf03f01ce2f2fe37373382dd4 | |
| ToppCell | mild_COVID-19_(asymptomatic)-RBC|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 2.33e-05 | 171 | 148 | 6 | 78491478ba65bad45238fe114f5251b2adea323d | |
| ToppCell | droplet-Fat-Scat-21m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-05 | 173 | 148 | 6 | f13124b4cf2ac1dc2895f90f5487d6ac681b0ba4 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-arterial_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.49e-05 | 173 | 148 | 6 | 3a9e9a09b3eeb37cbe56d650e112a8398879477f | |
| ToppCell | AT1_cells-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 2.49e-05 | 173 | 148 | 6 | b29816427428c7053017477f59b828bf1357f3b2 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_2|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 2.65e-05 | 175 | 148 | 6 | bde785ff0c854646d7ab8571359e9d69a7bf013f | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Endothelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-05 | 176 | 148 | 6 | 27e5115fae5f0f63b333bc99fbf6a6d4c9182c46 | |
| ToppCell | facs-Heart-RV-18m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-05 | 176 | 148 | 6 | fb3d03f64592e1df1d9785d9f2e70938d7ff9ce8 | |
| ToppCell | facs-Heart-RV-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-05 | 176 | 148 | 6 | 3270a36fc91a5583646ffeb70bfcbc5af7292aac | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.74e-05 | 176 | 148 | 6 | 1df7b6ce2519ad99bacbbaf1a8d5929e11513faa | |
| ToppCell | facs-Heart-RV-18m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-05 | 176 | 148 | 6 | 99410c121f55adbc7fcc013c8fa8905a45dba76b | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.83e-05 | 177 | 148 | 6 | 3d955ea938a1d2fb1b6d68d4997fd454bd632dfc | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-05 | 178 | 148 | 6 | ba2f0585626988b511046630bc16be5c5fec3fb2 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-endo_arterial_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.92e-05 | 178 | 148 | 6 | c227da59dc7beb73f84405bf13356bdeb59d9338 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.01e-05 | 179 | 148 | 6 | 4f6ca313b78aa93557937a046c44dcf8bcc9963c | |
| Drug | Flurandrenolide [1524-88-5]; Down 200; 9.2uM; PC3; HT_HG-U133A | 5.63e-06 | 192 | 151 | 9 | 7378_DN | |
| Drug | Piribedil hydrochloride [78213-63-5]; Down 200; 12uM; MCF7; HT_HG-U133A | 6.39e-06 | 195 | 151 | 9 | 3512_DN | |
| Drug | NS-398; Down 200; 10uM; PC3; HT_HG-U133A | 6.39e-06 | 195 | 151 | 9 | 6892_DN | |
| Drug | Torsemide [56211-40-6]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 6.66e-06 | 196 | 151 | 9 | 3517_DN | |
| Drug | Hydrocotarnine hydrobromide [5985-00-2]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 7.22e-06 | 198 | 151 | 9 | 6827_DN | |
| Drug | tautomycin | 1.40e-05 | 118 | 151 | 7 | CID000440646 | |
| Drug | halofuginone lactate | 2.19e-05 | 85 | 151 | 6 | CID000062891 | |
| Drug | krypton | 2.90e-05 | 27 | 151 | 4 | CID000005416 | |
| Drug | geldanamycin; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 4.23e-05 | 191 | 151 | 8 | 1008_DN | |
| Drug | Selegiline hydrochloride [14611-52-0]; Down 200; 17.8uM; MCF7; HT_HG-U133A | 4.55e-05 | 193 | 151 | 8 | 4146_DN | |
| Drug | 0316684-0000 [391209-55-5]; Down 200; 10uM; MCF7; HT_HG-U133A | 4.55e-05 | 193 | 151 | 8 | 7052_DN | |
| Drug | yohimbine; Up 200; 22.9uM; MCF7; HT_HG-U133A_EA | 4.72e-05 | 194 | 151 | 8 | 1119_UP | |
| Drug | Luteolin [491-70-3]; Down 200; 14uM; MCF7; HT_HG-U133A | 4.90e-05 | 195 | 151 | 8 | 5004_DN | |
| Drug | Prenylamine lactate [69-43-2]; Down 200; 9.6uM; PC3; HT_HG-U133A | 4.90e-05 | 195 | 151 | 8 | 5070_DN | |
| Drug | Solanine alpha [20562-02-1]; Up 200; 4.6uM; HL60; HT_HG-U133A | 4.90e-05 | 195 | 151 | 8 | 2152_UP | |
| Drug | Berberine chloride [633-65-8]; Down 200; 10.8uM; PC3; HT_HG-U133A | 5.08e-05 | 196 | 151 | 8 | 7143_DN | |
| Drug | Prostaglandin E1; Down 200; 10uM; PC3; HT_HG-U133A | 5.08e-05 | 196 | 151 | 8 | 6571_DN | |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A | 5.08e-05 | 196 | 151 | 8 | 1628_DN | |
| Drug | Demeclocycline hydrochloride [64-73-3]; Down 200; 8uM; MCF7; HT_HG-U133A | 5.26e-05 | 197 | 151 | 8 | 3404_DN | |
| Drug | Dorzolamide hydrochloride [130693-82-2]; Down 200; 11uM; PC3; HT_HG-U133A | 5.26e-05 | 197 | 151 | 8 | 5785_DN | |
| Drug | nifedipine; Down 200; 10uM; MCF7; HG-U133A | 5.26e-05 | 197 | 151 | 8 | 335_DN | |
| Drug | Carbarsone [121-59-5]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 5.26e-05 | 197 | 151 | 8 | 3250_DN | |
| Drug | Phenindione [83-12-5]; Down 200; 18uM; MCF7; HT_HG-U133A | 5.46e-05 | 198 | 151 | 8 | 5991_DN | |
| Drug | Fenofibrate [49562-28-9]; Down 200; 11uM; MCF7; HT_HG-U133A | 5.46e-05 | 198 | 151 | 8 | 7474_DN | |
| Drug | Avermectin B1 [71751-41-2]; Down 200; 4.8uM; MCF7; HT_HG-U133A | 5.46e-05 | 198 | 151 | 8 | 7218_DN | |
| Drug | Oleandomycin phosphate [7060-74-4]; Up 200; 5uM; HL60; HG-U133A | 5.46e-05 | 198 | 151 | 8 | 2018_UP | |
| Drug | Heptaminol hydrochloride [543-15-7]; Down 200; 22uM; PC3; HT_HG-U133A | 5.46e-05 | 198 | 151 | 8 | 1825_DN | |
| Drug | Gleevec; Down 200; 10uM; MCF7; HG-U133A | 5.65e-05 | 199 | 151 | 8 | 366_DN | |
| Drug | Dibucaine [85-79-0]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 5.65e-05 | 199 | 151 | 8 | 1469_DN | |
| Disease | anemia (implicated_via_orthology) | 4.86e-05 | 15 | 143 | 3 | DOID:2355 (implicated_via_orthology) | |
| Disease | No-Reflow Phenomenon | 6.97e-05 | 3 | 143 | 2 | C0232347 | |
| Disease | Slow-Flow Phenomenon | 6.97e-05 | 3 | 143 | 2 | C2713615 | |
| Disease | Colorectal Carcinoma | MKRN3 ANK2 KALRN SYNE1 ABCA10 ABCA9 NCDN FBXO30 MMRN2 PRKD1 DMD CDH5 | 1.67e-04 | 702 | 143 | 12 | C0009402 |
| Disease | Leukemia, Myelocytic, Acute | 2.05e-04 | 173 | 143 | 6 | C0023467 | |
| Disease | Drug habituation | 2.49e-04 | 115 | 143 | 5 | C0013170 | |
| Disease | Drug abuse | 2.49e-04 | 115 | 143 | 5 | C0013146 | |
| Disease | Prescription Drug Abuse | 2.49e-04 | 115 | 143 | 5 | C4316881 | |
| Disease | Substance-Related Disorders | 2.49e-04 | 115 | 143 | 5 | C0236969 | |
| Disease | Drug Use Disorders | 2.49e-04 | 115 | 143 | 5 | C0013222 | |
| Disease | Drug Dependence | 2.49e-04 | 115 | 143 | 5 | C1510472 | |
| Disease | Substance Dependence | 2.49e-04 | 115 | 143 | 5 | C0038580 | |
| Disease | Substance Use Disorders | 2.49e-04 | 115 | 143 | 5 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 2.49e-04 | 115 | 143 | 5 | C0029231 | |
| Disease | Substance abuse problem | 2.60e-04 | 116 | 143 | 5 | C0740858 | |
| Disease | colipase measurement | 3.45e-04 | 6 | 143 | 2 | EFO_0801485 | |
| Disease | breast carcinoma | ARHGAP24 SLC4A7 NRAP CPNE5 LAX1 TXK CEP120 WDR11 PPA2 MTMR3 GPC5 BAIAP2 DMD NOTCH2 | 4.49e-04 | 1019 | 143 | 14 | EFO_0000305 |
| Disease | Arrhythmogenic right ventricular cardiomyopathy | 4.82e-04 | 7 | 143 | 2 | cv:C0349788 | |
| Disease | melanocyte protein PMEL measurement | 6.41e-04 | 8 | 143 | 2 | EFO_0801792 | |
| Disease | Malignant neoplasm of breast | RAD51 THEMIS2 TFAP2D ANK2 KALRN SYNE1 GGA3 MTMR3 UTP20 DMD SPEN CDH5 CPSF3 NOTCH2 | 7.51e-04 | 1074 | 143 | 14 | C0006142 |
| Disease | heart rate variability measurement | 7.67e-04 | 37 | 143 | 3 | EFO_0008003 | |
| Disease | resting heart rate | 8.15e-04 | 149 | 143 | 5 | EFO_0004351 | |
| Disease | BRCA1 mutation carier status | 8.21e-04 | 9 | 143 | 2 | EFO_0011021 | |
| Disease | centronuclear myopathy X-linked (implicated_via_orthology) | 8.21e-04 | 9 | 143 | 2 | DOID:0111225 (implicated_via_orthology) | |
| Disease | lifestyle measurement, systolic blood pressure | 8.21e-04 | 9 | 143 | 2 | EFO_0006335, EFO_0010724 | |
| Disease | osteoarthritis, hip | 1.06e-03 | 92 | 143 | 4 | EFO_1000786 | |
| Disease | platelet component distribution width | THEMIS2 SLC4A7 SH2B3 KALRN SYNE1 SLC44A2 TXK VPS9D1 DENND2C PLEC RAB11FIP3 | 1.17e-03 | 755 | 143 | 11 | EFO_0007984 |
| Disease | pulse pressure measurement | ARHGAP24 SLC4A7 ANK2 COL27A1 SYNPO2L PGBD1 CPNE5 P3H4 DHX15 SPTBN4 DIP2A JUP PPP3CA CEP120 MYPN KLB | 1.20e-03 | 1392 | 143 | 16 | EFO_0005763 |
| Disease | Liver Cirrhosis, Experimental | RBL2 SLC44A2 ABLIM3 CD163 TGFB3 LIMK2 MYL9 AGL SLC4A4 CDH5 SP140 | 1.42e-03 | 774 | 143 | 11 | C0023893 |
| Disease | aspartate aminotransferase measurement | SLC4A7 SH2B3 KALRN PIEZO1 DVL2 CD163 TXK DHX15 WDR11 SLC18A1 MYPN SLC4A4 | 1.55e-03 | 904 | 143 | 12 | EFO_0004736 |
| Disease | diastolic blood pressure, systolic blood pressure | SLC4A7 ANK2 DNAH7 DHX15 KIAA1671 CEP120 MYL9 SOCS5 MMRN2 CPSF3 | 1.63e-03 | 670 | 143 | 10 | EFO_0006335, EFO_0006336 |
| Disease | forced expiratory volume | ARHGAP24 SYNE1 PIEZO1 SLC44A2 ABLIM3 CEP120 WDR11 PIK3C2B AGL MYPN GPC5 | 1.65e-03 | 789 | 143 | 11 | EFO_0004314 |
| Disease | lymphocyte count | THEMIS2 SLC4A7 SH2B3 KALRN PIEZO1 DENND3 LAX1 DIP2A SLC45A3 PPA2 BTN2A3P RIPOR1 PLEC CTDSPL NOTCH2 SP140 | 2.01e-03 | 1464 | 143 | 16 | EFO_0004587 |
| Disease | breast cancer (is_marker_for) | 2.12e-03 | 185 | 143 | 5 | DOID:1612 (is_marker_for) | |
| Disease | left ventricular diastolic function measurement | 2.31e-03 | 54 | 143 | 3 | EFO_0008204 | |
| Disease | Diffuse Large B-Cell Lymphoma | 2.43e-03 | 55 | 143 | 3 | C0079744 | |
| Disease | multiple sclerosis | 2.51e-03 | 594 | 143 | 9 | MONDO_0005301 | |
| Disease | PR interval | 2.93e-03 | 495 | 143 | 8 | EFO_0004462 | |
| Disease | respiratory symptom change measurement, response to placebo | 3.02e-03 | 17 | 143 | 2 | EFO_0008344, EFO_0010068 | |
| Disease | urate measurement, bone density | 3.30e-03 | 619 | 143 | 9 | EFO_0003923, EFO_0004531 | |
| Disease | Adenocarcinoma of lung (disorder) | 3.37e-03 | 206 | 143 | 5 | C0152013 | |
| Disease | Cardiomyopathies | 3.75e-03 | 130 | 143 | 4 | C0878544 | |
| Disease | response to ziprasidone | 4.18e-03 | 20 | 143 | 2 | GO_0097337 | |
| Disease | Joubert syndrome 1 | 4.61e-03 | 21 | 143 | 2 | C4551568 | |
| Disease | gestational age | 4.63e-03 | 138 | 143 | 4 | EFO_0005112 | |
| Disease | anorexia nervosa | 4.81e-03 | 70 | 143 | 3 | MONDO_0005351 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AGDVSFYNMRDRSHI | 426 | Q96KV6 | |
| SETETGEARHSLYMF | 446 | Q9H0X4 | |
| SREALHTAGYEMSLN | 551 | O94929 | |
| TDYHELGRSIATLMS | 566 | P48751 | |
| DVKFSHSGRYMLTRD | 286 | Q9Y2T4 | |
| SGSRYLIRSDDMIET | 636 | O15013 | |
| YTGDFSRQEDRHLMA | 176 | Q9UKF6 | |
| RGTLLTTHYMSEAEA | 1391 | Q8WWZ4 | |
| VGRSHITALADYAMR | 1051 | O43306 | |
| ERGALLTTHYMAEAE | 1471 | Q8IUA7 | |
| LSDMGYVHRDLAARN | 791 | P54756 | |
| RAGLNEMVEYITHSR | 146 | Q14738 | |
| TYESASLRMFHLGRT | 451 | P43155 | |
| MFADYLAHESRRDSI | 86 | O14579 | |
| RIEHYASRLAEMENS | 3436 | P11532 | |
| AEDDLSHYTRLLRTM | 221 | P16066 | |
| MSKRHRLDLGEDYPS | 1 | O43143 | |
| HMDTVRTLCSAEDRY | 1166 | A2RUS2 | |
| MDPDAARHSIGYSIR | 396 | P33151 | |
| ERHLAGYESSSTLMT | 186 | O14641 | |
| DGAMTRTHTVTYREA | 56 | Q6P1M9 | |
| DAEIRHDGSNSYRLM | 11 | Q7Z6R9 | |
| MGYSHSLVIARDESE | 491 | Q9P258 | |
| RLTYTSTDEHDAMDG | 506 | Q9H2T7 | |
| DYSGRGELSARQMHL | 231 | Q06609 | |
| SSSMGLQEYHSRARE | 646 | O75154 | |
| GTAHADSEYERRMMS | 736 | Q9NVH2 | |
| SRSSFDMYHLSREGR | 146 | Q8N109 | |
| RSMSESYTLEGNDLH | 71 | Q08999 | |
| SHASYLRDSAVMDDS | 911 | Q01484 | |
| SGAIAAMRYAETHRV | 76 | O75884 | |
| TGEMALHLAARYSRA | 1876 | Q04721 | |
| QDSSGDYSLAHVREM | 66 | Q15139 | |
| RDGYRSSVLDIDALM | 1191 | Q9BY89 | |
| RLQAGEETASHYRMA | 706 | Q9UBB6 | |
| AGEHSGRYEELARML | 51 | Q99685 | |
| NERMYRSGDAESLHR | 1476 | Q86VF7 | |
| HYSREELNSMTLGEV | 216 | Q9NYK6 | |
| IRSLEELSDAMHGTY | 296 | P78333 | |
| ELDHTVSMQYGLTRD | 621 | P53671 | |
| YTLEDMRATLTRHVD | 396 | Q9H8L6 | |
| LARHTDDEMTGYVAT | 171 | Q16539 | |
| SSTQDGEIMHTRYEL | 281 | A6NEK1 | |
| DAYRMLSRLSGREHS | 106 | O95671 | |
| SRSSFDMYHLSREGR | 146 | Q8NHK3 | |
| GSMALSNHYRSEDLL | 161 | Q9UK99 | |
| DHLRELLTTMGDRFT | 121 | P24844 | |
| DDHYRTGTRFSGVDM | 446 | Q5GLZ8 | |
| LMVESHRSLRDDYEV | 306 | P51570 | |
| IMSVASRLSEAGHYA | 371 | O60229 | |
| LARHADAEMTGYVVT | 171 | O15264 | |
| EDLGRHESRSMRIFS | 101 | Q8IWV1 | |
| DMYHLSTEGEAHERR | 156 | Q14952 | |
| MLLHYSQEDSSDGDR | 231 | Q9NZ52 | |
| GALVHSRTYDMDVRL | 216 | Q96RT7 | |
| GRTALHYAAASDMDR | 471 | Q8N8A2 | |
| TLRSVYDGEEHGRFM | 36 | Q9Y2D4 | |
| ISSHFLLDDGMETRR | 186 | Q9UKK3 | |
| HSLAEILRSEYSSGM | 781 | Q9H8H2 | |
| SSRETGHSPDRRYAM | 251 | Q9Y2T5 | |
| MELLHSRNEGTATYA | 631 | P14923 | |
| RYLDLRIAHMLEGSE | 101 | Q9NUJ7 | |
| SEHDDLRRDVSSMYN | 326 | O95672 | |
| HMLDILRSGSDIQDY | 341 | O00750 | |
| GDRDRMTANHESYLL | 91 | Q8N264 | |
| GRSSLTRLASHMAEY | 2591 | Q9P2D7 | |
| RYDHQSRLTAREAME | 306 | Q8NEV1 | |
| GFDGSRRHTSMERYD | 386 | Q53G59 | |
| LMRYDGTTLRDGEHD | 536 | Q14185 | |
| DGYISHRELGDCMRT | 146 | P57796 | |
| ERDTLMRTGVYNHED | 951 | Q8N960 | |
| MRTGVYNHEDRIISE | 956 | Q8N960 | |
| SREDDVYSMLHRLCN | 261 | O15194 | |
| VHSGLAYTMERSARQ | 506 | P00367 | |
| SAMHGDSHDRYERLT | 96 | Q5T3F8 | |
| GRQSVTRLAAHMADY | 2346 | Q8WXX0 | |
| SRRSVAFDLDMHDGR | 141 | Q8IZC6 | |
| GHYSLNMTVTERGER | 831 | Q68D51 | |
| RYDHQSRLTAREAME | 306 | P68400 | |
| RRSMCYSDGRSLHLE | 831 | Q69YH5 | |
| VMHEQLAGSRYDSDR | 831 | Q86Z14 | |
| SEAIRRIHNGESMSY | 346 | O60256 | |
| MEYSRLRGEAGSDVS | 281 | Q8IWA5 | |
| GSLDETLELRGMRYH | 1456 | Q14689 | |
| DEDGRSLLSQMLHYD | 256 | P24941 | |
| RTAAALDRESMERHY | 386 | Q9NYQ7 | |
| STSGRVDREHMESYE | 496 | Q9NYQ7 | |
| NDRDGLTDMTLLHYA | 111 | Q96DZ5 | |
| RGISDSRMADIYHID | 441 | Q8TB52 | |
| MVLLEDSGSADFRRH | 6 | Q86VB7 | |
| GSAYHAARRDMLDAL | 206 | Q13115 | |
| SILRAHEAQDAGYRM | 276 | Q08209 | |
| FRDYIDRSGNHILSM | 506 | Q86YQ8 | |
| RDYVDRTGNHVLSMA | 526 | Q9HCH3 | |
| SRSHLDDDGMSVYTD | 1011 | Q13615 | |
| MRDERAALASVGHLY | 171 | O60422 | |
| IDCYHDMTAGRRSIA | 631 | Q96J94 | |
| YLDMELARAGSRASE | 356 | Q9H987 | |
| HETGRESTLEMIAYL | 2296 | O75691 | |
| YHEIGRSIATLMTDE | 481 | Q9Y6M7 | |
| HGIIADDMISRYALS | 1466 | O60522 | |
| RRERRYGVSSVHDMD | 151 | O75159 | |
| DHDYDLSRDLESAMS | 8286 | Q8NF91 | |
| YRLRALGERHTMDLT | 246 | Q9BXJ8 | |
| SRAMRRLGLDDAEYA | 356 | P55055 | |
| RRNSYRGHESEDSMS | 1211 | Q92859 | |
| SSRYEHGLMKDLSRG | 1026 | Q9C0A6 | |
| TGSRRAMALYHTEER | 26 | Q9H2U2 | |
| MHISSLEYAAGDITR | 326 | Q96JS3 | |
| ISSISGRDDLMDYHR | 416 | Q86SQ0 | |
| RRTHLASDDLYKLSM | 226 | Q9H7B2 | |
| TEARRHYDEGVRMGS | 311 | Q96JT2 | |
| DHTTMNDDARTELYR | 531 | Q9NY61 | |
| YTRVLDSDGSDRLHM | 431 | Q9UQB8 | |
| MARDAHGNTALTYAR | 651 | A6NIR3 | |
| AETMSRGLSYLHEDV | 291 | Q13705 | |
| TDTTGEQHLRDEYMS | 1891 | A4UGR9 | |
| GTDDRHSVADGEMYR | 586 | Q9UN79 | |
| SGLYDEAIRHFSTML | 156 | Q8NBP0 | |
| YLLDGMRAEEHQRVS | 306 | Q9Y5T5 | |
| IRLSDEYMGTHASLS | 316 | Q8IVF5 | |
| LYESLMAAHASRDRV | 56 | Q4VC31 | |
| RYSHDLSGRKMATEG | 116 | Q13064 | |
| RRNVRSVYATMGDHE | 1901 | Q96T58 | |
| EGHSRRDMFEILTRY | 126 | Q13496 | |
| HLTNGDLRREMVYAS | 271 | Q9C0H9 | |
| SGYHLEGDRSRICME | 151 | O60687 | |
| RYLMAGISDEDSLAR | 151 | O75038 | |
| RSSTEDMERALSEYL | 221 | Q92791 | |
| VEEMSDSRRYSLADL | 431 | Q5TEJ8 | |
| EDTEILDSAMYRSRA | 1561 | Q9C0C2 | |
| RYHMDASGEAVSETL | 21 | Q8IX01 | |
| DDLVSMTHVYEDLRG | 191 | Q8WWF5 | |
| DTEYEVSLISRRGDM | 866 | P24821 | |
| RDSDYEMDSSSRSHL | 551 | Q9UQQ2 | |
| EAAHSLTLGRYEQME | 2276 | Q9H254 | |
| EDRLMAEREYGSCSH | 1086 | Q15149 | |
| RDSRHLGSYTISVFM | 176 | P42681 | |
| SYHEIGRAIATLMSD | 336 | Q9Y6R1 | |
| GLRDRSFISEQMYEH | 66 | Q13342 | |
| HGTMSDVLRAERYLL | 1536 | Q92508 | |
| HRAREAALSRSMELY | 466 | Q9Y2B5 | |
| AETLHSMRYFDRAAL | 1141 | Q9BZH6 | |
| LAEATRGHREYTESM | 181 | Q6ZS17 | |
| RGHREYTESMCLLES | 186 | Q6ZS17 | |
| EMLTELVHRGSVYDA | 101 | Q9HC21 | |
| THVAMRGNSDYADLS | 516 | Q96GX1 | |
| ALYNSTRELLEEMHG | 71 | P10600 | |
| MSLSHLYRDGEGRID | 1 | Q9UBB9 | |
| EAALGMDRRTDAYSR | 1321 | P49815 | |
| SMADLKHSSLRYELR | 321 | Q7Z402 | |
| ASVYTDDHERGRAMG | 216 | P54219 | |
| LIREAMSAYNSHEEG | 576 | P35573 | |
| RERISMHQDTTGYAC | 1216 | Q86TC9 | |
| GSTERNIRSNYRDMH | 686 | Q14957 |